T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
First Financial Corporation Common Stock
THFF
$687M
| $1.03M | ﹤0.01% |
21,082
+701
| +3% | +$34.3K |
|
1927
Collegium Pharmaceutical
COLL
$1.1B
| $1.03M | ﹤0.01% |
34,538
+1,400
| +4% | +$41.8K |
|
|
FARO
1928
DELISTED
Faro Technologies
FARO
| $1.03M | ﹤0.01% |
37,750
+621
| +2% | +$17K |
|
1929
Navient
NAVI
$1.3B
| $1.03M | ﹤0.01% |
81,543
+1,583
| +2% | +$20K |
|
1930
CommScope
COMM
$3.69B
| $1.03M | ﹤0.01% |
192,934
-7,624
| -4% | -$40.5K |
|
1931
Trupanion
TRUP
$1.92B
| $1.03M | ﹤0.01% |
27,490
+14,516
| +112% | +$541K |
|
1932
G-III Apparel Group
GIII
$1.16B
| $1.02M | ﹤0.01% |
37,270
+1,705
| +5% | +$46.7K |
|
1933
Artivion
AORT
$1.88B
| $1.02M | ﹤0.01% |
41,300
+1,811
| +5% | +$44.6K |
|
1934
Annexon
ANNX
$274M
| $1.01M | ﹤0.01% |
524,741
-579,644
| -52% | -$1.12M |
|
1935
Universal Technical Institute
UTI
$1.48B
| $1.01M | ﹤0.01% |
39,448
+4,454
| +13% | +$114K |
|
1936
MannKind Corp
MNKD
$1.65B
| $1.01M | ﹤0.01% |
201,317
+26,308
| +15% | +$132K |
|
1937
Tandem Diabetes Care
TNDM
$817M
| $1.01M | ﹤0.01% |
52,843
+2,103
| +4% | +$40.3K |
|
|
MFA
1938
MFA Financial
MFA
$1.04B
| $1.01M | ﹤0.01% |
98,423
+4,669
| +5% | +$47.9K |
|
1939
BioCryst Pharmaceuticals
BCRX
$1.62B
| $1.01M | ﹤0.01% |
134,295
+7,489
| +6% | +$56.2K |
|
1940
Pennant Group
PNTG
$871M
| $1M | ﹤0.01% |
39,913
+3,967
| +11% | +$99.8K |
|
1941
Root
ROOT
$1.55B
| $1M | ﹤0.01% |
7,522
+1,782
| +31% | +$238K |
|
1942
Immuneering
IMRX
$327M
| $1M | ﹤0.01% |
659,009
-108,115
| -14% | -$164K |
|
|
CSR
1943
Centerspace
CSR
$963M
| $1M | ﹤0.01% |
15,467
+715
| +5% | +$46.3K |
|
1944
NeoGenomics
NEO
$1.04B
| $997K | ﹤0.01% |
104,962
+13,388
| +15% | +$127K |
|
1945
Wolverine World Wide
WWW
$2.45B
| $995K | ﹤0.01% |
71,481
+6,318
| +10% | +$87.9K |
|
1946
Par Pacific Holdings
PARR
$1.7B
| $994K | ﹤0.01% |
69,644
+9,832
| +16% | +$140K |
|
1947
Harmony Biosciences
HRMY
$1.87B
| $991K | ﹤0.01% |
29,839
+10,051
| +51% | +$334K |
|
1948
MRC Global
MRC
$1.23B
| $981K | ﹤0.01% |
85,398
+4,094
| +5% | +$47K |
|
1949
Brookdale Senior Living
BKD
$1.78B
| $980K | ﹤0.01% |
156,505
+16,934
| +12% | +$106K |
|
1950
Empire State Realty Trust
ESRT
$1.32B
| $980K | ﹤0.01% |
125,296
+6,442
| +5% | +$50.4K |
|